Research
June 27, 2024
UAMS Winthrop P. Rockefeller Cancer Institute Awarded Five New Grants from National Cancer Institute
![UAMS Winthrop P. Rockefeller Cancer Institute Awarded Five New Grants from National Cancer Institute](https://news.uams.edu/wp-content/uploads/2024/06/NCI-Funding-Featured-Image--150x150.png)
Researchers at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) have been awarded five new grants from the National Cancer Institute (NCI) in 2024, totaling $4.6 million. New grants include: $3.3 million NCI grant to create a Melanoma Resistance Evolution Atlas, Principal Investigator: Alan Tackett, Ph.D., Winthrop P….
May 31, 2024
Cancer Institute Research Retreat Focuses on Prevention, Early Detection
![UAMS cancer researchers talk about a study displaying on a poster in front of them](https://news.uams.edu/wp-content/uploads/2024/05/Retreat-Poster-Session-150x150.png)
The third UAMS Winthrop P. Rockefeller Cancer Institute Cancer Research Retreat brought together more than 250 UAMS cancer researchers and faculty to share ongoing research on the prevention and early detection of cancer in Arkansas. An alarming statistic prompted the retreat’s prevention and early detection focus in the hopes that collaboration and sharing innovative strategies…
April 2, 2024
Distinguished Cancer Researcher, Yong Zhu, Ph.D., Joins UAMS Winthrop P. Rockefeller Cancer Institute Leadership
![Dr. Yong Zhu in his research lab](https://news.uams.edu/wp-content/uploads/2024/04/Yong-Zhu-Featured-Image--150x150.png)
Prominent cancer epidemiologist, Yong Zhu, Ph.D., has joined the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute as associate director for population science and translational science. He also holds an appointment as professor of epidemiology in the UAMS Fay W. Boozman College of Public Health. Zhu joins UAMS after serving for…
March 26, 2024
UAMS Awarded $11.48 Million Federal Grant to Establish Center for Molecular Interactions in Cancer
![Dr. Robert Eoff](https://news.uams.edu/wp-content/uploads/2024/03/Eoff-featured-image-1-150x150.jpg)
The University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute received a five-year, $11.48 million federal grant to create the Center for Molecular Interactions in Cancer (CMIC). The grant was awarded by the National Institute of General Medical Sciences (NIGMS) Centers of Biomedical Research Excellence (COBRE) program. COBRE grants are awarded to…
January 19, 2024
Arkansan Sees Advanced Cancer Disappear with Experimental Drug Offered at UAMS Winthrop P. Rockefeller Cancer Institute
![Dr. Michael Birrer speaks with a patient during a clinic visit](https://news.uams.edu/wp-content/uploads/2024/01/Dwight-Birrer--150x150.png)
A Little Rock man with resistant kidney cancer who underwent experimental immunotherapy in Phase 1 Clinical Trials at the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute has experienced a complete remission.
December 15, 2023
UAMS Myeloma Researcher Sees‘ Impressive’ Results in Clinical Trials of Bispecific Antibody Treatments
![Carolina Schinke, M.D.](https://news.uams.edu/wp-content/uploads/2023/12/Schinke_Carolina-2048x1367-1-150x150.jpg)
Many patients at the UAMS Myeloma Center have relapsed refractory myeloma, meaning they have nearly run out of effective treatment options. Fortunately, the center has talented clinical researchers like Carolina Schinke, M.D., with access to the latest medications, including promising study drugs. Schinke is leading a clinical trial at UAMS of a promising new bispecific…
December 14, 2023
UAMS Researcher Takes Aim at Drug-Resistant Myeloma
![Fenghuang (Frank) Zhan, M.D., Ph.D.](https://news.uams.edu/wp-content/uploads/2023/12/Fenghuang-150x150.jpeg)
UAMS Myeloma Center researcher Fenghuang (Frank) Zhan, M.D., Ph.D., has spent his career in search of clues to help fight drug-resistant myeloma. His findings recently led him to establish a translational research project to beat drug-resistant myeloma for his 11-member myeloma research team, based at the UAMS Winthrop P. Rockefeller Cancer Institute. While the…
Expanding the Field: Clinical Trials Diversity Benefits Myeloma Research
![Samer Al Hadidi, M.D.](https://news.uams.edu/wp-content/uploads/2023/12/Al-Hadidi_Samer_MD-12152021-850_1510-150x150.jpg)
Clinical trials have long been an established part of medical research. The University of Arkansas for Medical Sciences (UAMS) Myeloma Center and the Clinical Trials Office work together to create a more diverse pool of clinical trial participants in the continuing research of multiple myeloma. Samer Al Hadidi, M.D., is a driving force in this…
October 23, 2023
Five UAMS Researchers Awarded Grants for Breast Cancer Research
![UAMS professor Ping-Ching Hsu, Ph.D.,](https://news.uams.edu/wp-content/uploads/2023/10/Hsu_Ping-Ching-Cancer-10112023-EDL_0625-150x150.jpg)
For the 26th year during Breast Cancer Awareness Month, the Arkansas Breast Cancer Research Program (ABCRP) has awarded funding to kick-start promising breast cancer research projects. Since the passage of the Arkansas Breast Cancer Act in 1997 that created the ABCRP, the Arkansas State Legislature has set aside funds that UAMS invests in novel research…
September 25, 2023
UAMS Division of Research and Innovation Engages Researchers at Orientation and Administrative Showcase
![Christy Simecka, DACLAM, D.V.M., (front left), director, Division of Laboratory Animal Medicine, speaks with Susan Steelman, MLIS, AHIP; and (back left) Kerrey Roberto, director, Institutional Animal Care and Use Committee, talks to Dirk Haselow, M.D.](https://news.uams.edu/wp-content/uploads/2023/09/DLAM-IACUC-resize-150x150.jpg)
UAMS research faculty got to hear directly from Division of Research and Innovation staff during a fun and informative afternoon that featured brief presentations and concluded with a poster session and reception with drinks and light hors d’oeuvres.
Next page